Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishnu Meghana Cheekireddy

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of the American Pharmacists Association : Japha|February 8, 2022
Cost-related nonadherence can be explained by a general nonadherence frameworkQais Alefan, Vishnu Meghana Cheekireddy, David Blackburn
Current Therapeutic Research, Clinical and Experimental|August 2, 2017
Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated ReviewThangavel Mahalingam Vijayakumar, Jayasutha Jayram, Vishnu Meghana Cheekireddy, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmacists Association : Japha|February 8, 2022
Cost-related nonadherence can be explained by a general nonadherence frameworkQais Alefan, Vishnu Meghana Cheekireddy, David Blackburn
Current Therapeutic Research, Clinical and Experimental|August 2, 2017
Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated ReviewThangavel Mahalingam Vijayakumar, Jayasutha Jayram, Vishnu Meghana Cheekireddy, et al.
Pageof 1